Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer
Open Access
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 24 (12) , 1737-1745
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysisUrologic Oncology: Seminars and Original Investigations, 2018
- Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of lifeBJU International, 2016
- Patterns‐of‐care and health economic analysis of robot‐assisted radical prostatectomy in the Australian public health systemBJU International, 2015
- Symptoms, unmet needs, psychological well‐being and health status in survivors of prostate cancer: implications for redesigning follow‐upBJU International, 2015
- Mapping FACT-P to EQ-5D in a large cross-sectional study of metastatic castration-resistant prostate cancer patientsQuality of Life Research, 2014
- Active surveillance for clinically localized prostate cancer––A systematic reviewJournal of Surgical Oncology, 2014
- Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4Value in Health, 2012
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curvesBMC Medical Research Methodology, 2012
- Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations?Value in Health, 2010
- Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effectsStatistics in Medicine, 2002